Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Intraoperative Assessment of High-Risk Thyroid Nodules Based on Electrical Impedance Measurements: A Feasibility Study Publisher



Beheshti Firoozabadi J1, 2 ; Mahdavi R2, 3 ; Shamsi K1, 2 ; Ataee H2, 3, 4 ; Shafiee A2, 5 ; Ebrahiminik H6, 7 ; Chegini H2, 7 ; Hoseinpour P2, 8 ; Moradi A9 ; Yousefpour N1, 3 ; Aghaei F1, 3 ; Fardoost A1 ; Ghelichli A1, 3 ; Mokhtari Dowlatabad H2, 3 Show All Authors
Authors
  1. Beheshti Firoozabadi J1, 2
  2. Mahdavi R2, 3
  3. Shamsi K1, 2
  4. Ataee H2, 3, 4
  5. Shafiee A2, 5
  6. Ebrahiminik H6, 7
  7. Chegini H2, 7
  8. Hoseinpour P2, 8
  9. Moradi A9
  10. Yousefpour N1, 3
  11. Aghaei F1, 3
  12. Fardoost A1
  13. Ghelichli A1, 3
  14. Mokhtari Dowlatabad H2, 3
  15. Hajighasemi F2, 3
  16. Sami N10
  17. Rouhollah Miri S3, 11, 12
  18. Akbari ME1
  19. Abdolahad M1, 2, 3, 12
Show Affiliations
Authors Affiliations
  1. 1. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, 14166-34793, Iran
  2. 2. Nano Bioelectronics Devices Laboratory, School of Electrical and Computer Engineering, Faculty of Engineering, University of Tehran, Tehran, 14399-57131, Iran
  3. 3. Cancer Electronics Research Center, University of Tehran and Tehran University of Medical Sciences Imam Khomeini Hospital, Tehran, 14197-33141, Iran
  4. 4. Department of Electrical Engineering, Amirkabir University of Technology, Tehran, 15916-34311, Iran
  5. 5. Department of Surgery, Farmanieh Hospital, Tehran, 19537-34411, Iran
  6. 6. Department of Internentional Radiology and Radiation Sciences Research Center, Aja University of Medical Sciences, Tehran, 14117-18541, Iran
  7. 7. Interventional Radiology Department, Tirad Imaging Institute, Tehran, 15867-36513, Iran
  8. 8. Department of Pathology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, 15179-64311, Iran
  9. 9. Department of Pathology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, 14166-34793, Iran
  10. 10. Department of Medicine, Islamic Azad University of Medical Sciences, Tehran, 19395-1495, Iran
  11. 11. Department of Surgical Oncology, Tehran University of Medical Science, Tehran, 14176-14411, Iran
  12. 12. Cancer Institute, Imam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, 14166-34793, Iran

Source: Diagnostics Published:2022


Abstract

Precise diagnosis of thyroid nodules is challenging due to non-diagnostic/inconclusive results and uncertainties about the malignancy of follicular neoplasms (FNs), even in frozen-section pathology. Therefore, surgical management, especially in Bethesda III and IV categories, may be complicated, and sometimes a second surgery may be required. The Thyroid Nodule Impedance Measurement System (TN-IMS) consists of a metallic patch attached to submental skin and a G20 I.V. cannula inserted into the targeted nodules. Two impedance-based parameters named Z1kHz and impedance phase slope (IPS) in 100 kHz to 500 kHz of the thyroid nodules are recorded and compared with their histopathological results as the gold standard. TN-IMS was intra-surgically applied to 103 human thyroid nodules and normal thyroid tissues. A remarkable consistency between defined co-ranges of Z1kHz/IPS and the histopathological status of specimens was achieved (p < 0.001). Based on these measurements, it was concluded that intraoperative bioelectrical impedance scanning of thyroid nodules would be a helpful complementary approach to detecting high-risk excision-required thyroid nodules. © 2022 by the authors.
Other Related Docs
18. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
26. Iran National Cancer Control Program (Irnccp) in Practice, Scientific Journal of Kurdistan University of Medical Sciences (2021)
29. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)